Responses
Regular Abstracts – Part 2
Immune-Stimulants and Immune Modulators
1147-E UI-101, a TLR7/8 agonist encapsulated in cholesteryl pullulan nanoparticle targeting tumor-associated macrophages via binding to DC-SIGN, elicits potent anti-tumor immunity without severe side effect
Compose a Response to This Article
Other responses
No responses have been published for this article.
